THEMIS, a T cell-specific protein with high expression in CD4 + CD8 + thymocytes, has a crucial role in positive selection and T cell development. THEMIS lacks defined catalytic domains but contains two tandem repeats of a distinctive module of unknown function (CABIT). Here we found that THEMIS directly regulated the catalytic activity of the tyrosine phosphatase SHP-1. This action was mediated by the CABIT modules, which bound to the phosphatase domain of SHP-1 and promoted or stabilized oxidation of SHP-1's catalytic cysteine residue, which inhibited the tyrosine-phosphatase activity of SHP-1. Deletion of SHP-1 alleviated the developmental block in Themis −/− thymocytes. Thus, THEMIS facilitates thymocyte positive selection by enhancing the T cell antigen receptor signaling response to low-affinity ligands.
T cell development is a continuous process that begins when progenitor cells that originate in the fetal liver or adult bone marrow enter the thymus and are induced to commit to the T cell lineage. Thymocytes progress through multiple well-defined maturational steps that for simplicity are grouped into three main stages defined by expression of the co-receptors CD4 and CD8: CD4 − CD8 − (double negative (DN)), CD4 + CD8 + (double positive (DP)), and CD4 + or CD8 + (single positive: CD4SP or CD8SP, respectively). The transition of thymocytes through these stages of maturation is dependent upon signals transmitted by various cell-surface molecules, including Notch, cytokine receptors and precursor or mature forms of the T cell antigen receptor (TCR) 1, 2 .
All thymocytes are subjected to a selection process at the DP stage that is based on the affinity of their expressed TCR for self-peptide ligands bound to major histocompatibility complex (self-pMHC) that tests TCR functionality and enforces self-tolerance 3 . Thymocytes that express TCRs that fail to bind to self-pMHC or that bind with high affinity to self-pMHC are 'non-selected' or 'negatively selected' , respectively, and are triggered to undergo apoptotic death, whereas thymocytes that express TCRs that bind with low affinity to self-pMHC are 'positively selected' and progress to the CD4SP or CD8SP stage 3 . The affinity of the TCR for self-pMHC controls the intensity and duration of the TCR signaling response, which in turn leads to the differential activation of downstream signal-transduction pathways and transcriptional responses that dictate cell fate 4 .
Thymocyte selection is dependent upon the expression and function of several lineage-restricted effector molecules, including the protein tyrosine kinases (PTKs) LCK and ZAP-70, the protein tyrosine phosphatase (PTP) SHP-1 (encoded by Ptpn6), and specialized adaptors such as LAT and SLP-76 (refs. 5,6) . THEMIS, a T cellspecific protein, has an important role in thymocyte selection. In the absence of THEMIS, thymocyte development is partially blocked at the DP-to-SP transition stage, which results in a substantial reduction in mature CD4SP thymocytes and, to lesser extent, CD8SP thymocytes and peripheral T cells [7] [8] [9] [10] [11] .
THEMIS is the 'founding member' of a group of structurally related proteins that are defined by the presence of one or more copies of a CABIT ('cysteine-containing all beta in THEMIS') globular module with a median length of 261 amino acids that contains a conserved core motif (φXCX 7-26 φXLPφX 3 GXF, where 'φ' is any hydrophobic residue, 'X' is any amino acid, and the subscripted number indicates the number of residues) 9 . All members of the mammalian THEMIS family, including THEMIS, THEMIS2 (which is restricted to B cells and myeloid cells) and the more distantly related THEMIS3 (which is expressed in the large and small intestine 7 ) contain two tandem CABIT modules and a C-terminal proline-rich sequence but lack a known catalytic domain 9 . THEMIS binds directly to the cytosolic adaptor GRB2, and this interaction requires the proline-rich sequence of THEMIS 12, 13 . Mass-spectrometry screens of proteins coimmunoprecipitated with THEMIS have identified SHP-1 as a putative THEMIS-interacting protein 14, 15 , and it has been suggested that THEMIS functions by regulating the activity of SHP-1 or its recruitment to LAT 16, 17 . Nevertheless, a specific role for THEMIS in T cell development has not been clearly defined, and it remains unclear if its effect on TCR signaling is mainly activating or inhibitory [14] [15] [16] . A particular challenge has been to identify a function for the CABIT modules that constitute most of the THEMIS protein. The presence of highly conserved core sequences and their requirement for THEMIS activity in vivo 18 suggests that CABIT modules have an important biological role; however, their distinctiveness from all previously described protein domains indicates that they may perform a unique cellular function 9 .
In this study, we identify a biological function for the CABIT modules that clarifies the role of THEMIS in T cell development. We found that the THEMIS CABIT modules bound directly to the PTP domain of SHP-1 and inhibited the PTP activity of SHP-1 by promoting or stabilizing oxidation of the catalytic cysteine residue. That activity, coupled with the stage-specific regulation of THEMIS during T cell development [7] [8] [9] 11 , provides an explanation for the unusual sensitivity of DP thymocytes to TCR stimulation 19 , a property that is essential for positive selection.
RESULTS

Binding of THEMIS to the PTP domain of SHP-1
To determine if THEMIS binds directly to SHP-1, we first performed cell-free in vitro protein-binding assays. THEMIS bound to a glutathione S-transferase (GST)-SHP-1 fusion protein in the absence of GRB2, although the THEMIS-SHP-1 interaction was enhanced by GRB2 ( Fig. 1a) . In lysates of HEK-293 human embryonic kidney cells co-transfected with plasmids encoding SHP-1 and THEMIS lacking the GRB2-binding proline-rich sequence (THEMIS-1-493), SHP-1 immunoprecipitated together with THEMIS-1-493 ( Fig. 1b) . GRB2independent association of THEMIS and SHP-1 was also detected by co-immunoprecipitation of THEMIS with SHP-1 from lysates of GRB2-deficient total thymocytes ( Fig. 1c) .
SHP-2 (another dual Src-homology-2 (SH2) PTP that is closely related to SHP-1) bound to THEMIS when co-expressed in HEK-293 cells, but two other class I PTPs (PTPN1 and PTPN7) that are expressed in thymocytes did not bind to THEMIS (Supplementary Fig. 1a,b) . To locate the sequences within THEMIS that mediated its binding to SHP-1, we next performed co-immunoprecipitation experiments in HEK-293 cells transfected with plasmids encoding SHP-1 and various truncations of THEMIS. SHP-1 immunoprecipitated together with a THEMIS protein that contained only the CABIT1 and CABIT2 modules (THEMIS-1-493) and, to a lesser extent, with truncated THEMIS proteins containing only the CABIT1 module (THEMIS-1-260) or CABIT2 module (THEMIS-260-493) ( Fig. 1b) . In similar cotransfection experiments, a protein containing only the PTP domain of SHP-1 immunoprecipitated together with THEMIS-1-493 and with THEMIS-1-260 ( Fig. 1d) . Also, purified SHP-1 lacking both SH2 domains but containing the PTP domain (GST-∆SH2-SHP-1) bound to THEMIS-1-493 in vitro ( Fig. 1e and Supplementary Fig. 1c,d) . 
A r t i c l e s
Together these results demonstrated that the CABIT modules of THEMIS interacted directly with the PTP domain of SHP-1.
Inhibition of SHP-1's PTP activity by the THEMIS CABIT modules
To determine if THEMIS directly regulates the PTP activity of SHP-1, we used an in vitro assay to detect the release of phosphate from a tyrosine-phosphorylated peptide. The PTP activity of SHP-1 was diminished in the presence of THEMIS, and this correlated with the concentration of THEMIS ( Fig. 2a) . The PTP activity of SHP-1 was not inhibited by GRB2, which also binds to SHP-1, which demonstrated that the inhibitory effect was specific to THEMIS; however, the inhibition of SHP-1 was slightly greater when THEMIS and GRB2 were added together ( Fig. 2b) . In a similar assay, the PTP activity of SHP-2 was diminished slightly by THEMIS, whereas THEMIS did not inhibit the PTP activity of PTPN1 or PTPN7 ( Fig. 2c) . THEMIS-1-493 was nearly as effective as full-length THEMIS at inhibiting the PTP activity of SHP-1 ( Fig. 2d) , which indicated that the CABIT modules were responsible for this inhibitory function of THEMIS. THEMIS-1-260 also inhibited the PTP activity of SHP-1, although not as effectively as THEMIS-1-493, which contains both CABIT modules ( Fig. 2d) ; this indicated that a single CABIT module contained the sequences necessary for regulating the PTP activity of SHP-1 but that both CABIT modules were required for full inhibition. THEMIS2, which 'rescues' the developmental block in Themis −/− thymocytes when transgenically expressed in thymocytes, and therefore could substitute for THEMIS in vivo 13 , inhibited the PTP activity of SHP-1 ( Fig. 2e ) and, to a lesser extent, that of SHP-2, but not that of PTPN1 or PTPN7, in in vitro tyrosine-phosphatase assays ( Fig. 2c) . All mammalian CABIT modules contain a conserved cysteine residue (underlined below) within the core motif of φXCX 7-26 φXLPφX 3 GXF 9 . To determine the role of the cysteine residue in the regulatory activity of THEMIS, we introduced cysteine-to-alanine point substitutions in both the CABIT1 module (Cys153) and CABIT2 module (Cys413) of THEMIS (THEMIS-C-A). THEMIS-C-A immunoprecipitated together with SHP-1 in lysates of HEK-293 cells transfected to express THEMIS-C-A and SHP-1 (Supplementary Fig. 1e ) and inhibited the PTP activity of SHP-1 in an in vitro tyrosinephosphatase assay ( Fig. 2e) , which indicated that the cysteine residues in the CABIT domains were not essential for regulating the PTP activity of SHP-1. This was consistent with published observations that retrovirally encoded THEMIS-C-A is able to 'rescue' the DP-to-SP developmental block in Themis −/− thymocytes 20 . These A r t i c l e s results demonstrated that the THEMIS CABIT modules directly inhibited the PTP activity of SHP-1 and that the conserved core cysteine was not required for this function.
Deletion of Ptpn6 restores T cell development in Themis −/− mice
We next determined if inhibition of the PTP activity of SHP-1 would reverse the developmental block in Themis −/− thymocytes in an in vitro differentiation assay 21 . Overnight culture of immature (TCR lo ) DP thymocytes with plate-bound antibody to the TCR invariant chain CD3e (anti-CD3e) plus antibody to the adhesion molecule CD2 (anti-CD2), followed by 24 h of rest without stimulation, induces their progression to the CD4 + CD8 lo stage 21 , which replicates the initial stages of positive selection in vivo. In contrast to wild-type DP thymocytes, Themis −/− DP thymocytes exhibited an impaired ability to transition to the CD4 + CD8 lo stage 7 (Fig. 3) . The block in the progression of Themis −/− DP thymocytes to the CD4 + CD8 lo stage was significantly alleviated when the in vitro assay was performed in the presence of sodium stibogluconate, a selective inhibitor of SHP-1 (ref. 22) ( Fig. 3) ; this indicated that the enhanced PTP activity of SHP-1 in Themis −/− thymocytes contributed to the developmental defect.
To determine if the developmental block in Themis −/− thymocytes could be 'rescued' by a reduction in the expression of SHP-1, we generated Themis −/− Ptpn6 fl/fl Cd4-Cre mice, in which T cell-lineagespecific deletion of loxP-flanked alleles encoding SHP-1 (Ptpn6 fl/fl ), via Cre recombinase expressed via the T cell-specific Cd4 promoter, occurs mainly in DP thymocytes 23 . Thymocytes from Themis −/− Ptpn6 +/+ Cd4-Cre control mice exhibited normal maturation up to the DP stage but a marked reduction in the number of CD4SP thymocytes and, to lesser extent, CD8SP thymocytes and peripheral T cells ( Fig. 4a,b) , similar to the developmental phenotype of Themis −/− mice 7 . The expression of SHP-1 in total thymocytes from Themis −/− Ptpn6 fl/fl Cd4-Cre mice was reduced to approximately 25% that observed in total thymocytes from Themis −/− Ptpn6 +/+ Cd4-Cre mice, as assessed by densitometry ( Fig. 4c) . This reduction in the expression of SHP-1 alleviated the developmental block, as evinced by the significantly greater frequency and number of mature TCR hi CD4SP and CD8SP thymocytes and peripheral T cells in Themis −/− Ptpn6 fl/fl Cd4-Cre mice than in Themis −/− Ptpn6 +/+ Cd4-Cre mice ( Fig. 4a,b) . In contrast to Themis −/− Ptpn6 +/+ Cd4-Cre mice, which had a large frequency of peripheral T cells with a CD62L lo-neg CD44 hi memory T cell phenotype as a result of lymphopenia-induced expansion 7 , the frequency of CD62L lo-neg CD44 hi T cells in Themis −/− Ptpn6 fl/fl Cd4-Cre mice was similar to that in Themis +/+ Ptpn6 +/+ Cd4-Cre mice (Fig. 4a) . Deletion of Ptpn6 at an earlier stage of development (predominantly at the DN stage) through the use of an LCK-Cre transgene 23 resulted in a nearly complete absence of SHP-1 protein in total thymocytes and also substantially alleviated the developmental block caused by the deletion of Themis (Supplementary Fig. 2 ). Together these results indicated that the developmental defect in Themis −/− thymocytes was due to the enhanced PTP activity of SHP-1.
Regulation of active-site oxidation of SHP-1 by THEMIS All classical PTPs, including SHP-1 and SHP-2, contain a conserved active-site cysteine residue (with an unusually low acidic dissociation constant) that catalyzes the removal of phosphate from phosphorylated tyrosines 6 . However, the catalytically active deprotonated (S − ) thiolate state of the active-site cysteine is highly susceptible to oxidation by intracellular reactive oxygen species (ROS), which inactivate the PTP 6 . To determine if the binding of THEMIS to SHP-1 directly regulates the redox state of the active-site cysteine, we added pervanadate, a pan-tyrosine-phosphatase inhibitor that irreversibly oxidizes PTP active-site cysteine residues to the sulfonic acid (S-O 3 H) form 24 , to cell-free suspensions of GST-SHP-1 in the presence or absence of THEMIS. Oxidized SHP-1 was detected by immunoblot analysis with a monoclonal antibody specific for sulfonylated PTP active-site cysteines 25 . Oxidation of SHP-1 by pervanadate was enhanced in the presence of THEMIS, and this effect was most evident at concentrations of pervanadate that resulted in sub-maximal oxidation of SHP-1 ( Fig. 5a and Supplementary Fig. 3a) . THEMIS also increased the susceptibility of SHP-1 to oxidation by pervanadate in HEK-293 cells co-transfected to express THEMIS and SHP-1 ( Fig. 5b and Supplementary Fig. 3b) .
To evaluate the redox status of SHP-1 in Themis −/− thymocytes, we labeled catalytically active SHP-1 at the time of cell lysis by the addition of iodoacetyl-polyethylene glycol-biotin, which immediately and irreversibly binds to reduced, de-protonated (-S − ) cysteine thiols 25 . The abundance of catalytically active SHP-1 was slightly but consistently greater in Themis −/− total thymocytes and was lower in total thymocytes with transgenic expression of THEMIS 14 than in Themis +/+ (control) total thymocytes (Fig. 5c) . Lysis of thymocytes in the absence of PTP inhibitors resulted in the rapid oxidation and inactivation of SHP-1 (Supplementary Fig. 3c,d) ; consequently, we were unable to accurately evaluate the PTP activity of SHP-1 immunoprecipitated from thymocyte lysates by the tyrosine-phosphatase assay. However, SHP-1 was much less susceptible to oxidation by pervanadate in Themis −/− total thymocytes than in Themis +/+ total thymocytes ( Fig. 5d  and Supplementary Fig. 3e ). The susceptibility of SHP-1 to oxidation by pervanadate was restored in Themis −/− thymocytes with transgenic expression of THEMIS2 (ref. 13) ( Fig. 5e) , which demonstrated [26] [27] [28] . In the presence of THEMIS, active-site oxidation of SHP-1 by H 2 O 2 , assessed by immunoblot analysis with antibody to sulfonylated PTP active sites, was markedly increased (Fig. 5f) , which indicated that THEMIS regulated the redox state of SHP-1 in response to physiological ROS. Together these results demonstrated that THEMIS inhibited the PTP activity of SHP-1 by promoting or stabilizing ROS-mediated oxidation of the active-site cysteine residue of SHP-1.
p-SHP-1 does not correspond with PTP activity
We found that phosphorylation of SHP-1, which occurs at two C-terminal tyrosine residues (Tyr536 and Tyr564), was lower in Themis −/− total thymocytes than in Themis +/+ total thymocytes (Fig. 6a,b) , in confirmation of published results 16 . The amount of tyrosine-phosphorylated SHP-1 (p-SHP-1) in total thymocytes correlated with the expression of THEMIS protein, and the amount of p-SHP-1 was restored in Themis −/− thymocytes by expression of a transgene encoding THEMIS2 (ref. 13) ( Fig. 6a-c) . The lower abundance of p-SHP-1 in Themis −/− thymocytes has been interpreted as evidence of diminished catalytic activity of SHP-1 (ref. 16); however, phosphorylation of SHP-1 is not required for its PTP catalytic activity, and its physiological relevance has not been established 6, 29 . The amount of catalytically active SHP-1 in unstimulated Themis −/− total thymocytes was greater than, not less than, that in Themis +/+ total thymocytes ( Fig. 5c,f) . Because SHP-1 is a target of SHP-1's phosphatase activity 6, 29, 30 , we reasoned that the diminished amount of p-SHP-1 in Themis −/− thymocytes was secondary to increased auto-or transdephosphorylation by SHP-1. Indeed, treatment of both Themis +/+ total thymocytes and Themis −/− total thymocytes with pervanadate or H 2 O 2 , which inhibit SHP-1 activity, led to an increase in p-SHP-1 relative to its abundance in their untreated counterparts (Fig. 6d,e ).
Together these results demonstrated that SHP-1's phosphorylation status could not be used to predict its PTP catalytic activity and suggested that the lower abundance of p-SHP-1 in Themis −/− thymocytes was secondary to enhanced auto-or trans-dephosphorylation by SHP-1.
Themis −/− signaling defects in the presence of ROS In contrast to mature T cells, in which engagement of the TCR induces the production of ROS [31] [32] [33] , stimulation of thymocytes via the TCR failed to elicit ROS 34 (Supplementary Fig. 4a ). However, ROS are induced in thymocytes by stimulation with the lectin concanavalin A 34 , which engages multiple cell-surface molecules in addition to the TCR. Tyrosine-phosphorylation of the PTK ZAP-70 (p-ZAP-70), a known target of SHP-1 (refs. 6, 35) , at Tyr319 was lower in Themis −/− total thymocytes than in Themis +/+ total thymocytes following stimulation with concanavalin A (Fig. 7a) , whereas there was no difference between Themis −/− total thymocytes and Themis +/+ total thymocytes in their abundance of p-ZAP-70 following stimulation with anti-CD3 plus anti-CD4 (Fig. 7b,c) . However, when H 2 O 2 was added at the time of stimulation with anti-CD3 plus anti-CD4, the tyrosine-phosphorylation of ZAP-70 induced by this was lower in Themis −/− total thymocytes than in Themis +/+ total thymocytes (Fig. 7b) . In vitro cell culture promotes ROS production due to high oxygen tension as well as pro-oxidant metabolic and media effects 36 . Freshly harvested Themis −/− total thymocytes exhibited no clear defects in proximal TCR signaling responses relative to those of Themis +/+ total thymocytes (Fig. 7c) . However, after in vitro culture for 6 h, the tyrosine phosphorylation of ZAP-70, as well as the tyrosine-phosphorylation of LCK (phosphorylated at Tyr394), another putative target of SHP-1 (ref. 37) , was lower in Themis −/− total thymocytes than in Themis +/+ total thymocytes in response to either stimulation with anti-CD3 plus anti-CD4 (Fig. 7c,d) or stimulation with peptide presented by A r t i c l e s antigen-presenting cells (Supplementary Fig. 4b) . Themis −/− total thymocytes also exhibited less induction of tyrosine-phosphorylation of LCK and ZAP-70 in response to treatment with H 2 O 2 alone than that of Themis +/+ total thymocytes treated in an identical way (Fig. 7e) .
De-phosphorylation of ZAP-70 or of the related B cell PTK SYK by SHP-1 was inhibited by THEMIS in HEK-293 cells transfected with plasmids encoding ZAP-70 or SYK plus plasmid encoding SHP-1 and cultured under conditions in which ROS are constitutively produced 36 (Fig. 7f,g) . THEMIS-mediated inhibition of the PTP activity of SHP-1 in HEK-293 cells transfected with plasmids encoding SYK and SHP-1 (Supplementary Fig. 5a ) or in vitro (Supplementary Fig. 5b) was attenuated by the addition of the ROS scavenger N-acetyl-l-cysteine, which indicated that the redox regulation of SHP-1 by THEMIS was dependent upon ROS. Collectively, these results established a positive role for THEMIS in proximal TCR signaling by promoting or stabilizing the oxidation of SHP-1 by ROS.
DISCUSSION
Here we have shown that a critical function of THEMIS during T cell development is to negatively regulate the activity of the PTP SHP-1 in DP thymocytes and thereby enhance the TCR signaling response to low-affinity self-pMHC and enable positive selection. THEMIS promoted or stabilized oxidation of the catalytic cysteine of SHP-1, which inhibited its PTP activity, and this regulatory activity was conferred by the CABIT modules that bound directly to the PTP domain of SHP-1.
While it remains to be determined how the CABIT modules regulate the oxidation of SHP-1, several plausible mechanisms can be suggested on the basis of their inferred structure together with what is already known about the structure and redox regulation of SHP-1. CABIT modules, which are composed of multiple SH3-like βbarrel domains 9 , probably form an extensive protein-binding globular interface that specifically recognizes the PTP domain of SHP-1. The catalytic cysteine residue of all classical PTPs is housed inside a pocket with an aperture that allows the entry of only the phosphate moiety on tyrosine residues 38 . Thus, binding of the CABIT modules might prevent access of the oxidized catalytic cysteine of SHP-1 to reducing agents such as glutathione in the bulk solvent or to cytosolic Figure 6 The diminished tyrosine-phosphorylation of SHP-1 in Themis −/− thymocytes is caused by increased PTP activity of SHP-1. (a) Immunoblot analysis of SHP-1 phosphorylated at Tyr536 (p-SHP-1(Y536)) or Tyr564 (p-SHP-1(Y564)) and total SHP-1 (left margin) in Themis +/+ and Themis −/− total thymocytes left unstimulated (0) or stimulated for 1 or 3 min (above lanes) with anti-CD3 plus anti-CD4 (CD3+CD4). (b) Immunoblot analysis of SHP-1 phosphorylated at Tyr564 and total SHP-1, as well as total THEMIS (left margin), in total thymocytes obtained from mice with transgenic expression of THEMIS, and Themis +/+ , Themis +/− or Themis −/− mice (above blots). (c) Immunoblot analysis of tyrosine-phosphorylated and total SHP-1 (as in a; left margin) in total thymocytes obtained from Themis +/+ and Themis −/− mice and Themis −/− mice with transgenic expression of THEMIS2 (above blots) and stimulated as in a (above lanes). A r t i c l e s redox-regulatory proteins 39 . Alternatively, the CABIT modules might stabilize the PTP domain of SHP-1 in an unfolded state, which would expose the catalytic cysteine to oxidation by ROS or prevent reactivation of the oxidized catalytic cysteine by inhibiting intra-molecular relay of sulfenic acid to the two regulatory cysteine residues (Cys329 and Cys363) in SHP- 1 (refs. 40,41) . We note that our in vitro PTPinhibition data suggest that the inhibitory effect of THEMIS cannot be explained solely by redox regulation. Thus, binding of the CABIT modules probably also blocks access of the catalytic cysteine to phosphorylated-tyrosine ligands, a mechanism of inhibition that is not mutually exclusive with redox regulation.
Although the CABIT modules of THEMIS bound directly to SHP-1, experimental data suggest that the interaction of THEMIS with GRB2 is important for its in vivo function 12, 18, 20 . Co-binding of SHP-1 and THEMIS to GRB2 brings these proteins into close proximity and might facilitate and stabilize their direct interaction. In addition, following engagement of the TCR, GRB2, via its SH2 domain, recruits SHP-1 to tyrosine-phosphorylated ligands at the cell membrane, including LAT and CD28 (ref. 42) . Thus, the binding to GRB2 ensures that THEMIS is positioned to affect the activity of the cellular portion of SHP-1 that is presumably the most relevant to TCR signaling. Finally, GRB2 might also be needed to position SHP-1 and THEMIS near sites of ROS production by NADPH oxidases at the cell membrane.
It has been proposed that THEMIS enhances the activity of SHP-1, either directly or by assisting in its recruitment to LAT, and thereby acts to dampen TCR signaling in DP thymocytes 16 . According to that model, the PTP activity of SHP-1 is diminished in Themis −/− DP thymocytes, and engagement of the TCR by low-affinity ligands that normally promote positive selection results in the transduction of enhanced signaling responses that trigger negative selection 16 . Our results do not support that model. If the thymocyte-maturation defect of Themis −/− mice was caused by diminished SHP-1 activity, deletion of Ptpn6 or inhibition of the PTP activity of SHP-1 should not have 'rescued' , and might possibly have exacerbated, the block in T cell development in Themis −/− mice. Instead, inhibition of the PTP activity of SHP-1 or deletion of Ptpn6 in DP thymocytes alleviated the developmental block imposed by THEMIS deficiency; these results identified enhanced PTP activity of SHP-1 as the underlying cause of the maturational defect in Themis −/− thymocytes. It is also A r t i c l e s relevant that T cell development is not 'rescued 'in either Themis −/− mice deficient in BIM, a proapoptotic member of the BCL-2 family of prosurvival proteins (Bim −/− ) 14 or Themis −/− mice with transgenic expression of BCL-2 (ref. 7) , which indicates that the developmental block in Themis −/− thymocytes is not secondary to increased negative selection, as has been speculated 16 . It is well established that DP thymocytes are more sensitive to TCR stimulation than are mature T cells 19 . Although the mechanism(s) underlying this sensitivity has (have) remained unclear, the enhanced signaling ability of DP thymocytes is thought to be especially important for positive selection, which is mediated by signals generated from low-affinity TCR-self-pMHC interactions in the thymus. Our results, together with the profound block in positive selection exhibited by Themis −/− thymocytes, suggest that THEMIS might be responsible for the selective sensitivity of DP thymocytes to engagement of the TCR. Consistent with that, DP thymocytes have high expression of THEMIS, but its expression is downregulated as thymocytes transition to the SP stage and become less responsive to low-affinity self ligands 7 , a property that is necessary for the prevention of autoimmunity. Thus, stage-specific regulation of THEMIS represents a mechanism for transient and selective attenuation of SHP-1 activity in DP thymocytes to enable positive selection while preserving the SHP-1-mediated inhibitory pathway for limiting the responsiveness of mature T cells.
Our results suggest that in addition to regulating SHP-1, THEMIS might also regulate the activity of SHP-2, a closely related class I SH2 domain PTP. THEMIS bound to SHP-2, and the PTP activity of SHP-2 was attenuated by THEMIS (albeit only slightly in in vitro assays). If THEMIS does have an inhibitory effect on SHP-2 in thymocytes, this might help to explain the observation that under certain stimulatory conditions, the kinase ERK and calcium signaling responses to engagement of the TCR are enhanced in Themis −/− thymocytes 16 . Unlike SHP-1, which is thought to have an exclusively inhibitory role in signal transduction, SHP-2 positively regulates ERK and calcium-NFAT-mediated signaling 6, 43, 44 . However, it is notable that in contrast to the 'rescue' observed in Themis −/− Ptpn6 −/− mice, deletion of the gene encoding SHP-2 (Ptpn11) did not alleviate the block in positive selection in Themis −/− mice (data not shown), which would indicate that the main function of THEMIS in thymocytes is to regulate the catalytic activity of SHP-1.
Our results have also identified an important role for ROS in thymocyte selection. Published data have suggested that ROS might have a role in positive selection and the maturation of SP thymocytes, but this mechanism has not been investigated extensively 45, 46 . ROS, generated following the activation of T cells by the cell-membrane NADPH oxidase NOX2 or by mitochondria as a result of 'metabolic reprogramming' , or locally produced by macrophages at sites of inflammation, have been shown to positively regulate the activation and effector responses of mature T cells, in part by inhibition of SHP-1 (ref. 47 ). The origin of ROS production in the thymus remains to be elucidated and could include both intrinsic (thymocyte-derived) sources and extrinsic (cortical epithelial, dendritic cell or macrophage) sources. The defects in TCR signaling in Themis −/− thymocytes, which stem at least in part from diminished oxidative inactivation of SHP-1 by ROS, are most clearly revealed under conditions in which ROS are generated or present during TCR-co-receptor engagement. This provides an explanation for the relatively mild signaling defects and the contradictory results reported by studies in which activation of Themis −/− thymocyte was performed under conditions in which ROS are not present or are not produced 7, 8, 14, 16 .
Analysis of a comprehensive collection of over 100 species across the eukaryotic tree has revealed that the CABIT module is found only in metazoa and that its emergence correlates with the expansion of the phosphorylated-tyrosine signaling network 9 (data not shown). Together with the biochemical function established for THEMIS in our study here, this suggests that the CABIT module evolved in metazoa as a mechanism for regulating phosphorylated-tyrosine signaling. The sequence diversity outside the core sequence of CABIT modules raises the possibility that different CABIT modules might have evolved to interact with distinct PTPs. That, combined with organ-restricted or developmentally restricted expression of CABIT proteins, such as that exhibited by THEMIS, could represent a novel mechanism for selective regulation of PTK-PTP signaling responses in particular cellular contexts or during specific stages of maturation.
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